- Passing requires 71% on 100 scored items out of 120 total questions, in 3 hours.
- Genetic-test interpretation (32%) and patient communication (25%) make up 57% of the exam.
- 2025 results show 20 of 23 candidates passed - a rounded 87.0% rate calculated from NCBC's counts.
- Retakes need a 6-month wait; the first retake within 12 months carries no extra fee.
Difficulty Snapshot: What the Numbers Actually Say
"How hard is it?" is really two different questions when it comes to Cancer Genetic Risk Assessment certification: how hard is it to qualify to sit for the exam, and how hard is the exam itself once you're in the room (or on camera). Both matter, because the National Consortium of Breast Centers, Inc. (NCBC) does not let just anyone register. You need current unrestricted licensure as a physician, RN, APN, or PA, at least 60 relevant education/training hours in the preceding 5 years, and a minimum of 2 years of clinical cancer-genetics/risk-assessment experience before you're even eligible to book a seat.
Once you clear that bar, the exam itself is a 120-question, 3-hour, criterion-referenced test - 100 scored items and 20 unscored items mixed in without being labeled, so you never know which questions "count." The passing score is fixed at 71% correct on the scored items; there's no curve, no grading on a bell curve against other candidates that day. For a deeper breakdown of exactly what 71% means in raw numbers, see our dedicated CGRA Passing Score 2026 guide.
The most recent published results show 20 passed out of 23 candidates in 2025, which works out to a rounded 87.0% pass rate calculated directly from NCBC's own counts. A separate, smaller 2026 cohort of 5 candidates recorded 5 passes, but that's a tiny sample and not a completed-year rate, so it shouldn't be read as a trend. We go deeper into what these numbers do and don't tell you in CGRA Pass Rate 2026: What the Data Shows.
Why the CGRA Exam Feels Harder Than It Looks
On paper, a multiple-choice exam with a 71% passing threshold doesn't sound intimidating. In practice, candidates who underestimate this exam tend to make one of three mistakes.
- They treat it like a general oncology exam. The CGRA exam is narrowly focused on genetic risk assessment workflows - pedigree analysis, variant interpretation, and counseling - not broad cancer treatment knowledge.
- They underweight interpretation. Genetic-test interpretation alone is 32% of the exam, the single largest domain by a wide margin, and it demands fluency with variant classification, penetrance concepts, and result nuance that many clinicians only encounter occasionally in daily practice.
- They assume clinical experience alone is enough. Two years of practice builds intuition, but the exam still tests structured knowledge - specific criteria, classification systems, and communication frameworks - that intuition alone won't reliably reproduce under time pressure.
If you want a full map of what's actually tested before you decide how hard your personal prep will be, start with CGRA Exam Domains 2026: Complete Guide to All 5 Content Areas.
Which Domains Cause the Most Trouble
Not all five domains are created equal, and difficulty tends to track weight. The two heaviest domains - interpretation and communication - together account for 57% of your score, which means a mediocre grasp of either one can sink an otherwise strong performance.
Domain 3: Interpret Relevant Genetic Test Results (32%)
This is the exam's center of gravity. Candidates must reliably distinguish pathogenic, benign, and variant-of-uncertain-significance results, understand how test type and gene panel selection affect interpretation, and translate lab reports into clinically actionable conclusions.
- Expect scenario-based questions built around real report language
- Weak spots here disproportionately affect your overall score
- Review this domain more than any other single area
Domain 5: Effectively Communicate With and Counsel Patients (25%)
Despite being "soft skills" on the surface, this domain is tested with the same rigor as clinical content. Questions probe informed consent nuances, risk communication strategies, and how to handle emotionally complex family history conversations.
- Expect items that test judgment, not just recall
- Multiple "correct-sounding" answers are common - pick the most appropriate, not just a valid one
Domain 2: Perform Personalized Cancer Risk Assessment (18%)
This domain bridges history-taking and interpretation, testing your ability to apply risk models and translate family/personal history into a structured risk estimate.
Domain 1: Collect and Document Pertinent Patient and Family History (15%)
Foundational but still scored heavily enough to matter - pedigree conventions and documentation standards show up repeatedly.
Domain 4: Determine Medical Management Options (10%)
The smallest domain by weight, but don't skip it - questions link genetic findings to surveillance and management recommendations, an area candidates often review too lightly.
For a domain-by-domain breakdown of specific must-know topics and sample question patterns, see the full CGRA Exam Domains 2026 guide.
Format, Timing, and Question Style
The exam runs as NCBC-administered paper/pencil or live-remote-proctored testing; the currently linked administration policy names Examity as the remote-proctoring provider. If you test remotely, you'll need photo ID, a clear single-monitor workspace, a working webcam, microphone, and speakers, and you must be alone in the room - no phones, no headphones, and no unauthorized aids of any kind.
With 120 total questions (100 scored, 20 unscored) and a 3-hour limit, you have roughly 90 seconds per question on average - tight enough that you can't dwell on any single item, but workable if you've internalized the material rather than trying to reason everything out from scratch. Because the unscored items are unlabeled, treat every question as if it counts; there's no way to identify and skip the "practice" items.
Key Takeaway
Budget your exam-day pacing around 90 seconds per question, and don't burn extra time trying to guess which of the 120 items are unscored - you can't tell, and all 120 deserve full attention.
Who Struggles Most (and Why)
Because the prerequisites already screen for licensed physicians, RNs, APNs, and PAs with real clinical cancer-genetics experience, most candidates arrive reasonably prepared. Still, patterns emerge among those who find the exam harder than expected:
- Newer entrants to the field. Those closer to the 2-year experience minimum tend to have narrower exposure to rare variant scenarios and edge cases that show up in Domain 3.
- Candidates from adjacent specialties. Nurses or PAs who came from general oncology rather than dedicated genetics/risk-assessment roles sometimes need extra review of pedigree and classification conventions specific to this field.
- Candidates who skip structured review. Clinical experience builds intuition, but the exam rewards precise, criteria-based answers - which is why a dedicated CGRA Study Guide 2026: How to Pass on Your First Attempt matters even for seasoned clinicians.
It's worth noting that NCBC allows other qualified professionals to receive individual board review even if they don't fit the standard licensure pathway - so "who can sit for it" is slightly broader than the core categories suggest. Full eligibility detail lives in CGRA Requirements 2026: Eligibility, Prerequisites & How to Qualify.
| Factor | Detail |
|---|---|
| Passing threshold | 71% on scored items, criterion-referenced |
| Total questions | 120 (100 scored, 20 unscored) |
| Time limit | 3 hours |
| Heaviest domain | Domain 3, Genetic-Test Interpretation, 32% |
| Second-heaviest domain | Domain 5, Patient Communication/Counseling, 25% |
| 2025 published results | 20 passed of 23 candidates (≈87.0% rounded) |
A Domain-Weighted Prep Timeline
Generic study advice rarely accounts for the fact that two CGRA domains carry more than half the total weight. A smarter approach allocates study time proportionally, front-loading Domains 3 and 5 rather than splitting time evenly across all five.
Genetic-Test Interpretation (Domain 3)
- Drill variant classification categories and how they change clinical recommendations
- Work through sample lab-report language until interpretation feels automatic
Patient Communication and Counseling (Domain 5)
- Practice scenario questions involving informed consent and emotionally difficult disclosures
- Focus on selecting the "most appropriate" response among several plausible ones
Risk Assessment and History-Taking (Domains 1 and 2)
- Review pedigree documentation conventions
- Practice applying risk-assessment models to sample family histories
Medical Management (Domain 4) and Timed Review
- Connect genetic findings to surveillance/management recommendations
- Run full-length, timed practice sessions to build pacing at roughly 90 seconds per item
Use spaced repetition for the recall-heavy pieces of Domains 1 and 4, but reserve your scenario-based practice - the kind that mirrors real exam items - for Domains 3 and 5, since those are tested through judgment rather than pure recall. A structured, week-by-week plan with more detail is laid out in the CGRA Study Guide 2026, and you can pressure-test your pacing with timed sets on our practice test platform.
What Happens If You Don't Pass
Not passing on the first attempt isn't rare and it isn't catastrophic, but the retake rules are specific enough to plan around. You must wait at least 6 months between attempts. The first retake within 12 months carries no additional exam fee, which softens the financial blow of a near-miss. If you fail a second time, however, the next attempt costs the full $495 initial examination fee again.
This structure rewards a focused, well-timed retake rather than repeated quick attempts. If you fall short, spend the mandatory waiting period doing targeted review of your weakest domain - usually Domain 3 or Domain 5 given their weight - rather than a full restart of your study plan. For the complete fee breakdown across first attempts, retakes, and renewal, see CGRA Certification Cost 2026: Complete Pricing Breakdown.
It's also worth remembering that certification isn't the finish line. Annual renewal requires 8 cancer-genetics/risk-assessment education credits plus $150 and 3.1% processing; falling behind triggers inactive status 60 days past expiration and decertification a full year past expiration. Passing the exam is hard in the moment, but staying certified requires ongoing, low-key discipline afterward.
Frequently Asked Questions
Difficulty comparisons across certifications are unreliable because eligibility pools, domain weighting, and scoring methods differ. What's clear for this exam specifically: two domains, genetic-test interpretation and patient communication, carry 57% of the total weight, so difficulty is concentrated rather than evenly spread.
The eligibility requirement of 2 years of clinical cancer-genetics/risk-assessment experience helps, but the exam tests structured knowledge and criteria-based judgment under a 3-hour time limit. Most candidates benefit from at least some structured review of Domain 3 content, even with strong clinical backgrounds.
You need 71% or higher on the 100 scored items; the exam is criterion-referenced, meaning your score isn't adjusted relative to other candidates. See CGRA Passing Score 2026 for the full explanation.
Neither - the content and passing standard are identical whether you test paper/pencil or live-remote-proctored. Remote testing simply adds logistical requirements: a single-monitor setup, working webcam/microphone/speakers, and being alone in the room with no phones or headphones.
Not immediately. The first retake within 12 months of a failed attempt has no additional exam fee. A second failure, however, means your next attempt costs the full $495 fee again, so it pays to prepare thoroughly before that first retake.